January 5, 2026 - Health Technology Insights

January 5, 2026
HealthTech Media Room
HealthTech News, News, news

Flat Medical Appoints Eric Steen, Former B. Braun Executive, as Strategic Advisor

Medical Device Industry Veteran to Guide Capital Strategy and Market Expansion Flat Medical, a leader in precision safety technology for clinical procedures, announced the appointment of Eric Steen as...

January 5, 2026
HealthTech Media Room
HealthTech News, News, news

cliexaAI OUD Solution Qualifies on Mayo Clinic Platform

cliexa announced that its cliexaAI Opioid Use Disorder Solution has been recognized as a qualified solution on the Mayo Clinic Platform, marking a major step forward in the company’s...

January 5, 2026
HealthTech Media Room
HealthTech News, News, news

Natera Launches 21-Gene Fetal Focus Single-Gene NIPT

Natera, Inc., a global leader in cell-free DNA and precision medicine, announced the launch of Natera’s expanded 21-gene Fetal Focus single gene non-invasive prenatal test, supported by new findings...

January 5, 2026
HealthTech Media Room
HealthTech News, news, News

CareTrust Acquires $142 Million Mid-Atlantic Nursing Portfolio

CareTrust REIT, Inc. announced the acquisition of six skilled nursing facilities located in the Mid-Atlantic for a purchase price of approximately $142 million including transaction costs, effective January 1,...

January 5, 2026
HealthTech Media Room
HealthTech News, News, news

Incyte Reports Positive Topline Results for Tafasitamab in DLBCL

Based on these results, Incyte plans to file a supplemental Biologics License Application (sBLA) for tafasitamab and lenalidomide in addition to R-CHOP in first-line diffuse large B-cell lymphoma (DLBCL)...

January 5, 2026
HealthTech Media Room
HealthTech News, News, news

HELUS Pharma Advances Mental Health Therapies, Begins Nasdaq Trading

Helus Pharma builds on the strong foundation originally created as Cybin Inc., reflecting the Company’s ongoing transformation to a commercial stage pharmaceutical company Cybin Inc. doing business as Helus...

January 5, 2026
HealthTech Media Room
HealthTech News, News, news

RESET-RA Study Shows SetPoint System Effective for Rheumatoid Arthritis

Publication of 12-month outcomes reinforces SetPoint Medical’s pioneering role in advancing neuroimmune modulation as a new treatment paradigm for rheumatoid arthritis (RA) SetPoint Medical, a company dedicated to developing...

January 5, 2026
HealthTech Media Room
HealthTech News, News, news

Sonida Senior Living Secures $900 Million Debt for CNL Merger

Sonida Senior Living, Inc., a leading owner, operator and investor in senior living communities, announced that in connection with the previously announced definitive merger agreement with CNL Healthcare Properties, Inc, Sonida...

January 5, 2026
HealthTech Media Room
HealthTech News, News, news

GeneDx Leads Rare Disease Genomics with Unmatched Research and Clinical Impact in 2025

Industry-leading research powered by GeneDx Infinity accelerates the transition of genomics from discovery to the standard of clinical care, driving better outcomes for patients across healthcare settings GeneDx, a...

January 5, 2026
HealthTech Media Room
HealthTech News, News, news

Estrella Immunopharma Raises $8 Million via Nasdaq At-the-Market Offering

Estrella Immunopharma, Inc., a clinical-stage biopharmaceutical company developing CD19 and CD22-targeted ARTEMIS T-cell therapies to treat cancers and autoimmune diseases, announced that it has entered into definitive agreements with...

January 5, 2026
Health Tech Staff Writer
HealthTech News, News, news

State Health Reform Initiative Launched By Paragon Health Institute

Paragon Health Institute, a leading organization in healthcare research and policy development, has launched the State Health Reform Initiative to support state-level health policy implementation. The program, led by...

January 5, 2026
HealthTech Staff Writer
HealthTech News, News, news

Earendil Labs Partners with Sanofi to Develop Bispecific Antibodies

Earendil Labs, a global leader in AI-driven biologics discovery, announced a strategic collaboration with Sanofi to develop bispecific antibodies targeting autoimmune and inflammatory diseases. Under the agreement, Sanofi will...